Indeed, DEN exposure reduced UCB-derived CD34+ cell proliferation capacity, in line with the observation of the antiproliferative effect of DEN in both healthy and cancer settings,13,16,17,51,52 and self-renewing potential. The gene discussed is CD34; the disease is cancer.